
- Psychiatric Times Vol 23 No 11
- Volume 23
- Issue 11
Obituary
Wayne S. Fenton, MD, died in Washington, DC, on September 3, 2006.
Wayne S. Fenton, MD, died in Washington, DC, on September 3, 2006. According to an announcement from the Washington Psychiatric Society (WPS) and the American Psychiatric Association (APA), Dr Fenton was the director of the division of adult translational research and associate director for clinical affairs at the National Institute of Mental Health (NIMH).
Much of his work at the NIMH was geared to the development of new diagnostic instruments and interventions for mental illness, including schizophrenia. It was anticipated that improving cognitive impairment in persons with severe disorders would enable them to live in the community. In addition, as the NIMH liaison to the APA and the World Psychiatric Association, Dr Fenton helped shape the agenda for the forthcoming DSM-V.
In his private practice, Dr Fenton often treated the most seriously ill patients. The WPS-APA announcement stated: "His tragic death is a huge loss to the psychiatric community and to the nation." Thomas Insel, director of the NIMH, described him as, " . . . without question one of the nation's experts in schizophrenia." Dr Fenton's contributions to psychiatric research and dedication to improving the lives of the most seriously ill patients stand as his legacy.
Articles in this issue
almost 19 years ago
Treatment-Resistant Anxiety Disorders: Neurotrophic Perspectivesalmost 19 years ago
Enlisting Family Members to Address Treatment Refusal in Substance Abusersalmost 19 years ago
Neurotransmitters, Pharmacologic Synergy, and Clinical Strategiesalmost 19 years ago
Augmentation Strategies in Treatment-Resistant Depressionalmost 19 years ago
Pathology and Management of Treatment Resistance in Bipolar Disorderalmost 19 years ago
Treatment Resistance in Schizophrenia: The Role of Alternative Therapiesabout 19 years ago
Book Review: Pediatric Neuropsychiatryabout 19 years ago
BBP from the GGBabout 19 years ago
Better Tools Needed to Measure Treatment Outcomeabout 19 years ago
NIDA Confirms Benefit of Drug Treatment Programs for Criminal OffendersNewsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.